Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury
Open accessThe DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Abstract
Neutrophil gelatinase-associated lipocalin (Ngal), also known as siderocalin, forms a complex with iron-binding siderophores (Ngal:siderophore:Fe). This complex converts renal progenitors into epithelial tubules. In this study, we tested the hypothesis that Ngal:siderophore:Fe protects adult kidney epithelial cells or accelerates their recovery from damage. Using a mouse model of severe renal failure, ischemia-reperfusion injury, we show that a single dose of Ngal (10 microg), introduced during the initial phase of the disease, dramatically protects the kidney and mitigates azotemia. Ngal activity depends on delivery of the protein and its siderophore to the proximal tubule. Iron must also be delivered, since blockade of the siderophore with gallium inhibits the rescue from ischemia. The Ngal:siderophore:Fe complex upregulates heme oxygenase-1, a protective enzyme, preserves proximal tubule N-cadherin, and inhibits cell death. Because mouse urine contains an Ngal-dependent siderophore-like activity, endogenous Ngal might also play a protective role. Indeed, Ngal is highly accumulated in the human kidney cortical tubules and in the blood and urine after nephrotoxic and ischemic injury. We reveal what we believe to be a novel pathway of iron traffic that is activated in human and mouse renal diseases, and it provides a unique method for their treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The finding that NGAL was one of the most highly expressed proteins following ischaemia-reperfusion injury in kidney cells [372-374], and prognostic of kidney damage long before the more traditional marker creatinine was raised significantly, has led to considerable interest in this protein, especially as a marker of renal injury [375-389]”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxygen-Derived Free Radicals in Postischemic Tissue Injury
Epstein, F. H., & McCord, J. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120305 · Cited by 5,399
[1] Role of free radicals and catalytic metal ions in human disease: An overview
Halliwell, B., & Gutteridge, J. M. C. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)86093-b · Cited by 4,994 · cited 1×
“Unbound iron can catalyze the conversion of H2O2 to OH and OH– (the Haber-Weiss reaction) or form reactive ferryl or perferryl species (4).”
BackgroundCloning and characterization of a mammalian proton-coupled metal-ion transporter
Gunshin, H., Mackenzie, B., Berger, U. V., Gunshin, Y., Romero, M. F., Boron, W. F., Nussberger, S., Gollan, J. L., & Hediger, M. A. (1997) · Nature · doi:10.1038/41343 · Cited by 3,166 · cited 1×
“Cells acquire iron from carrier proteins (transferrin) or from cell surface iron transporters (divalent metal transporter) (1, 22).”
BackgroundMishra, J., Ma, Q., Prada, A., Mitsnefes, M., Zahedi, K., Yang, J., Barasch, J., & Devarajan, P. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000088027.54400.c6 · Cited by 1,749 · cited 4×
“To examine the functional significance of Ngal expression in renal ischemia, we first reproduced a common model of renal damage (44, 46) but used mice.”
BackgroundMethodInfluentialSelf-citationGoetz, D. H., Holmes, M. A., Borregaard, N., Bluhm, M. E., Raymond, K. N., & Strong, R. K. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00708-6 · Cited by 1,355
Hentze, M. W., & Kühn, L. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8175 · Cited by 1,292 · cited 1×
“hypoxia (32), oxidative stress (33, 34), and phosphorylation (35), changes in their activity may play an important role in ischemic disease, particularly by regulating the expression of ferritin (36–38).”
BackgroundReduced stress defense in heme oxygenase 1-deficient cells
Poss, K. D., & Tonegawa, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10925 · Cited by 1,291 · cited 1×
“Low doses of iron or heme, or other iron donors (78, 79), induce HO-1 (56, 80).”
BackgroundHeme oxygenase 1 is required for mammalian iron reutilization
Poss, K. D., & Tonegawa, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10919 · Cited by 1,016 · cited 1×
“the proximal tubule (85) by a large number of insults (56), and it prevents iron overload in both mouse (86) and human (85) proximal tubules.”
BackgroundThe lipocalin protein family: structural and sequence overview
Flower, D. R., North, A. C. T., & Sansom, C. E. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(00)00148-5 · Cited by 868
Determination of serum creatinine by a direct colorimetric method
Heinegård, D., & Tiderström, G. (1973) · Clinica Chimica Acta · doi:10.1016/0009-8981(73)90466-x · Cited by 720
Research works printed but not linked: 1
- Sephton, R.G., Hodgson, G.S., De Abrew, S., and Harris, A.W. 1978. Ga67 and Fe59 distributions in mice. J. Nucl. Med. 19 :930-935.
Cited by
Items 601–700 of 969
Tanahashi, H., Iwamoto, H., Yamaguchi, K., Sakamoto, S., Horimasu, Y., Masuda, T., Nakashima, T., Ohshimo, S., Fujitaka, K., Hamada, H., et al. (2024) · Respiratory Research · doi:10.1186/s12931-024-02825-y · Cited by 13
“Previous studies have demonstrated the protective effects of recombinant LCN2 against ischemia-reperfusion kidney injury in vivo and LPS-induced cellular injury in vitro [32, 33].”
Játiva, S., Torrico, S., Calle, P., Muñoz, Á., García, M., Larque, A. B., Poch, E., & Hotter, G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113415 · Cited by 12
Yewale, R. V., & Ramakrishna, B. (2022) · Hepatology Research · doi:10.1111/hepr.13847 · Cited by 12
“on endocytosis by proximal tubule, making it a potential biomarker of renal tubular damage.(83) Raised levels can be identified in plasma and urine within 2–4 h after a “structural” kidney injury induced by ischemic/nephrotoxic insults.”
BackgroundBiotherapy of experimental acute kidney injury: emerging novel therapeutic strategies
Li, N., Han, L., Wang, X., Qiao, O., Zhang, L., & Gong, Y. (2023) · Translational research · doi:10.1016/j.trsl.2023.06.002 · Cited by 14
Clinical biomarkers in kidney diseases
Rezzani, R. (2009) · Frontiers in Bioscience-Scholar · doi:10.2741/s88 · Cited by 14
Gong, L., Yu, H., Zhuge, Y., & Yu, Q. (2012) · Renal Failure · doi:10.3109/0886022x.2012.678173 · Cited by 15
“Mori et al.(4) found that a single dose of NGAL (10 μg) dramatically protected the kidney and mitigated azotemia using a mouse model of renal ischemia/reperfusion (I/R) injury (IRI).”
InfluentialAdvances in the Detection, Mechanism and Therapy of Chronic Kidney Disease
Dong, Y. J., Qu, X., Wu, G., Luo, X., Tang, B., Wu, F., Fan, L., Sooranna, D., & Liang, T. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191119094354 · Cited by 13
Yazdani, M. R., Merrikhi, A., Beni, Z. N., Baradaran, A., Soleimani, N., & Musazade, H. (2014) · PubMed Central · Cited by 12
Hisamichi, M., Kamijo‐Ikemori, A., Sugaya, T., Ichikawa, D., Hoshino, S., Hirata, K., Kimura, K., & Shibagaki, Y. (2016) · Biomarkers · doi:10.3109/1354750x.2016.1153723 · Cited by 12
“Further, NGAL expression is upregulated in the loop of Henle or distal tubules and urinary excretion of NGAL is increased by I/R (Mori et al., 2005).”
BackgroundRamirez-Sandoval, J. C., Barrera‐Chimal, J., Simancas, P. E., Rojas-Montaño, A., Correa‐Rotter, R., Bobadilla, N. A., & Morales-Buenrostro, L. E. (2013) · Biomarkers · doi:10.3109/1354750x.2013.867536 · Cited by 11
“Some of these biomarkers are urinary neutrophil gelatinase-associated lipocalin (uNGAL) (Haase et al., 2009; Mishra et al., 2003; Mori et al., 2005), kidney injury molecule-1 (uKim-1) (Han et al., 2002; Ichimura et al., 1998; Vaidya et al., 2006, 2010; Zhang et al., 2007), interleukin-18 (uIL-18)…”
BackgroundUrinary biomarkers--silver bullets to faster drug development and nephron protection
Haase, M., & Mertens, P. R. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq504 · Cited by 11
Kumar, S., Patel, M. L., & Pushkar, D. (2017) · Indian Journal of Critical Care Medicine · doi:10.4103/ijccm.ijccm_315_17 · Cited by 11
Bauer, C., Sim, M., Prince, R. L., Zhu, K., Lim, E. M., Byrnes, E., Pavlos, N. J., Lim, W. H., Wong, G., Lewis, J. R., et al. (2023) · Bone · doi:10.1016/j.bone.2023.116861 · Cited by 11
“LCN2 has been established as a biomarker for acute kidney injury as glomeruli in the kidney are involved in filtering circulating LCN2 [28] and it is suggested to play a role in pathways involved in the development and progression of CKD [8,29].”
BackgroundJochmans, I., Monbaliu, D. R. L., & Pirenne, J. (2011) · Transplantation Proceedings · doi:10.1016/j.transproceed.2011.09.035 · Cited by 11
Bandele, O. J., Camacho, L., Ferguson, M. S., Reimschuessel, R., Stine, C. B., Black, T. N., Olejnik, N., Keltner, Z., Scott, M., da Costa, G. G., et al. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.09.022 · Cited by 11
“Similar to the proposed renoprotective attributes of KIM-1, CLU, and OPN, NGAL and TIMP-1 have also been linked to regenerative processes in response to renal damage (Miya et al., 2011; Mori et al., 2005; Sola et al., 2011; Srisawat et al., 2010; Wang et al., 2008).”
BackgroundFujiwara, Y., Tsuchiya, H., Sakai, N., Shibata, K., Fujimura, A., & Koshimizu, T. (2016) · Journal of Inflammation · doi:10.1186/s12950-016-0116-5 · Cited by 12
“The LCN2 proteins produced at sites of inflammation are rapidly secreted into the systemic circulation, pass through the glomeruli, and are completely reabsorbed by renal proximal tubular cells via the scavengerreceptor megalin and cubilin-dependent endocytosis [25–28].”
BackgroundIn vivo mechanism study of NGAL in rat renal ischemia-reperfusion injury
Zang, X., An, S. X., Feng, Z., Xia, Y. P., Song, Y., & Yu, Q. (2014) · Genetics and Molecular Research · doi:10.4238/2014.october.27.15 · Cited by 13
“Mori et al. (2005) reported that in the early stage of severe renal failure in the mouse I/R model, a single dose of NGAL (10 μg) afforded significant renal protection and reduced azotemia.”
BackgroundCharacteristics of an Ideal Biomarker of Kidney Diseases
BENNETT, M. R., & Devarajan, P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803014-1.00001-7 · Cited by 19
Self-citationModern biomarkers of acute kidney injury
Иванович, К. Д., & Омарасхабович, М. М. (2023) · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · doi:10.17749/2070-4909/farmakoekonomika.2023.171 · Cited by 11
Omerika, L., Rašić, S., & Serdarević, N. (2014) · PubMed · Cited by 11
Intraoperative biomarkers in renal transplantation
Lohkamp, L., Öllinger, R., Chatzigeorgiou, A., Illigens, B. M. W., & Siepmann, T. (2015) · Nephrology · doi:10.1111/nep.12556 · Cited by 13
“Additionally, its concentrations in blood and urine were shown to correlate with those of serum creatinine and severity of renal impairment in acute renal injury in both, rodents and humans.(43,47) A systematic review and meta-analysis on NGAL’s predictive and diagnostic potential in AKI done by Haase et al.”
BackgroundTichelaar, J. W., Wesselkamper, S. C., Chowdhury, S., Yin, H., Berclaz, P., Sartor, M. A., Leikauf, G. D., & Whitsett, J. A. (2007) · Experimental Lung Research · doi:10.1080/01902140701703226 · Cited by 11
Lipocalin-2 Serum Levels Are Increased in Acute Hepatic Failure
Roth, G. A., Nickl, S., Lebherz-Eichinger, D., Schmidt, E. M., Ankersmit, H. J., Faybik, P., Hetz, H., & Krenn, C. G. (2013) · Transplantation Proceedings · doi:10.1016/j.transproceed.2012.02.047 · Cited by 11
“Overexpression of LCN-2 can protect cells from oxidative stress in vitro and ameliorate renal ischemia-reperfusion damage in vivo.(19,24,27) Hence, we suggest that increased serum levels of LCN-2 may be the consequence of immune hyperactivation by high levels of pro-inflammatory cytokines often seen in acute hepatic f…”
BackgroundZekey, F., Şenkul, T., Ateş, F., Soydan, H., Yılmaz, Ö., & Baykal, K. V. (2012) · Urology · doi:10.1016/j.urology.2012.02.015 · Cited by 13
Urinary Apolipoprotein M as a Biomarker of Acute Kidney Injury in Children Undergoing Heart Surgery
Svarrer, E. M. M., Andersen, H. Ø., Helvind, M. H., Slagman, M. C. J., Navis, G. J., Dullaart, R. P. F., Dahlbäck, B., & Nielsen, L. B. (2015) · Biomarkers in Medicine · doi:10.2217/bmm.15.105 · Cited by 11
Modern biomarkers of renal damage in pediatrics
Смирнова, Н. Н., Галкина, О. В., Новикова, В. П., & Прокопьева, Н. Э. (2019) · Nephrology (Saint-Petersburg) · doi:10.24884/1561-6274-2019-23-4-112-118 · Cited by 11
“А с другой стороны, необходимо глубокое понимание физиологической и патофизиологической роли, определение чувствительности и специфичности при поражении различных частей нефрона в момент острого процесса и в период восстановления, определение референсных значений, и, самое главное, целесообразность их использования пр…”
Perioperative Acute Renal Injury: Revisiting Pathophysiology
Sladen, R. N. (2024) · Anesthesiology · doi:10.1097/aln.0000000000004993 · Cited by 10
“26”
Acute kidney injury biomarkers in the single-cell transcriptomic era
Hinze, C., & Schmidt-Ott, K. M. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00079.2022 · Cited by 10
Self-citationNon-invasive assessment of IgA nephropathy severity with [18F]AlF-NOTA-FAPI-04 PET/CT imaging
Wang, H., He, L., Feng, L., Zhang, W., Liu, N., & Zhang, W. (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae340 · Cited by 10
Alternative Protein Scaffolds as Novel Biotherapeutics
Gebauer, M., & Skerra, A. (2015) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4939-2543-8_13 · Cited by 13
Albert, C., Kube, J., Haase‐Fielitz, A., Dittrich, A., Schanze, D., Zenker, M., Kuppe, H., Hetzer, R., Bellomo, R., Mertens, P. R., et al. (2014) · Biomarkers in Medicine · doi:10.2217/bmm.14.85 · Cited by 10
Sekar, D., Brüne, B., & Weigert, A. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0809543 · Cited by 10
“Whereas CLP were prone to pDC generation, thus yielding higher numbers of pDC, MP developed faster into pDC, which produced higher levels of IFN- [13].”
BackgroundKaraolanis, G., Katsaros, A., Palla, V., Lionaki, S., Moris, D., Karanikola, E., Kravaritou, M., Drossos, Psarros, T., Triantafillou, K., et al. (2015) · PubMed · Cited by 10
Wang, E., Chiou, Y., Jeng, W. Y., Lin, H.-K., Lin, H., Chin, H.-J. G., Wang, C. L., Yu, S.-S., Tsai, S.-C., Chiang, C.-Y., et al. (2016) · Kidney International · doi:10.1016/j.kint.2016.09.005 · Cited by 11
Negrin, L. L., Hahn, R., Heinz, T., & Hajdú, Š. (2018) · BioMed Research International · doi:10.1155/2018/2687584 · Cited by 11
“In AKI, however, a fraction of sNGAL may escape reabsorption due to proximal tubular injury, resulting in minimal uNGAL-levels [51].”
BackgroundFerreira, J. P., Rossignol, P., Bakris, G. L., Mehta, C. R., White, W. B., & Zannad, F. M. (2021) · American Journal of Nephrology · doi:10.1159/000519436 · Cited by 12
Ijaz, M. U., Alvi, K., Khan, H. A., Imran, M., Afsar, T., Almajwal, A. M., Amor, H., & Razak, S. (2023) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2023.102830 · Cited by 10
Salom, D., Sanz-Marco, E., Mullor, J. L., Lopez-Prats, M. J., Delpech, S. G., Udaondo, P., Millán, J. M., Arévalo, J. F., & Díaz-Llopis, M. (2010) · PubMed Central · Cited by 10
Iwashita, Y., Kuwabara, T., Hayata, M., Kakizoe, Y., Izumi, Y., Iiyama, J., Kitamura, K., & Mukoyama, M. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00519.2015 · Cited by 10
Self-citationGao, C., Zhang, L., Zhang, Y., Wallace, D. P., Lopez‐Soler, R. I., Higgins, P. J., & Zhang, W. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00279.2017 · Cited by 10
Ronco, C., Lullo, L. D., & McCullough, P. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44942-7.00111-4 · Cited by 10
Tidbury, N., Browning, N., Shaw, M., Morgan, M., Kemp, I., & Matata, B. M. (2019) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x19666190415115106 · Cited by 10
Jou-Valencia, D., Koeze, J., Popa, E. R., Aslan, A., Zwiers, P. J., Molema, G., Zijlstra, J. G., van Meurs, M., & Moser, J. (2019) · Critical Care Explorations · doi:10.1097/cce.0000000000000047 · Cited by 10
“org 9 distal tubules and collecting ducts, corroborating previous findings (34).”
ResultAvigan, Z. M., Singh, N., Kliegel, J. A., Weiß, M., Moeckel, G. W., & Cantley, L. G. (2021) · Transplantation Direct · doi:10.1097/txd.0000000000001168 · Cited by 10
Vanmassenhove, J., Glorieux, G., Hoste, E. A. J., Dhondt, A., Vanholder, R. C., & Biesen, W. V. (2014) · International Urology and Nephrology · doi:10.1007/s11255-014-0822-y · Cited by 10
“Using delta Ngal might not be an exact numerical reflection of the final result of this complex process, but one can easily appreciate that in case of an intact tubule, filtered Ngal can be integrally reabsorbed, and no local production of Ngal occurs, resulting in a net negative delta Ngal [11, 12].”
BackgroundElmas, A. T., Tabel, Y., & İpek, S. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.806900 · Cited by 10
Renal stress in vivo in real-time--visualised by the NGAL reporter mouse
Haase, M., Mertens, P. R., & Haase‐Fielitz, A. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr248 · Cited by 10
Biomarkers in acute kidney injury and cirrhosis
Lima, C., & Macedo, E. M. (2024) · Journal of Translational Critical Care Medicine · doi:10.1097/jtccm-d-23-00014 · Cited by 9
Cipriani, C., Pepe, J., Colangelo, L., Fassino, V., Occhiuto, M., Biondi, P., Nieddu, L., & Minisola, S. (2019) · Clinical Endocrinology · doi:10.1111/cen.14064 · Cited by 9
Qian, S., Huang, Y., Wang, N., Ding, Y., Qi, J., & Yu, Y. (2018) · World Journal of Urology · doi:10.1007/s00345-018-2488-z · Cited by 9
Funabashi, S., Omote, K., Nagai, T., Honda, Y., Nakano, H., Honda, S., Iwakami, N., Hamatani, Y., Nakai, M., Nishimura, K., et al. (2020) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872620901986 · Cited by 9
“019 Malignancy 108 (15) 28 (12) 36 (15) 44 (19) 0.”
Liu, Z., Shang, A., Chen, Z., Li, Y., & Hong-jun, Q. (2020) · Medicine · doi:10.1097/md.0000000000021386 · Cited by 9
Yamanouchi, S., Kimata, T., Akagawa, Y., Akagawa, S., Kino, J., Tsuji, S., & Kaneko, K. (2021) · Pediatric Nephrology · doi:10.1007/s00467-020-04863-2 · Cited by 9
“Although urinary NGAL may potentially originate from peripheral blood neutrophils or epithelial cells of the collecting ducts of the kidney [17], we believe that urinary NGAL originates from renal tubular cells, which produce and release NGAL into the urine.”
BackgroundLEDITZKE, K., Wagner, M. E. H., Neunaber, C., Clausen, J., & Winkelmann, M. (2021) · In Vivo · doi:10.21873/invivo.12560 · Cited by 9
Ramachandran, B., Sadasivam, K., Kapalavai, S. K., & Krupanandan, R. (2022) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24147 · Cited by 9
Cullin 3 mutant causing familial hyperkalemic hypertension lacks normal activity in the kidney
Maeoka, Y., Cornelius, R. J., Ferdaus, M. Z., Sharma, A., Nguyen, L. T., & McCormick, J. A. (2022) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00153.2022 · Cited by 9
Westenfelder, C. S., & Gooch, A. M. (2022) · Kidney360 · doi:10.34067/kid.0006372022 · Cited by 9
“4 mechanism and various novel therapies also work via upregulation of HO-1, which includes the actions of both the intrinsic and administered NGAL:siderophore:Fe complex [12] and the administration of Angiotensin 1-7 that activates the Mas Receptor[13].”
BackgroundBiomarkers in Acute Kidney Injury
Naud, J.-F., & Leblanc, M. (2008) · Biomarker Insights · doi:10.4137/bmi.s450 · Cited by 10
Autoantibodies and other biomarkers – pathological consequences (1)
Giles, I., & Putterman, C. (2008) · Lupus · doi:10.1177/0961203307088248 · Cited by 9
LV, Z., Xu, L., Shen, Z., Zhang, F.-R., Xu, X., & Li, E. (2009) · Oncology Letters · doi:10.3892/ol_00000019 · Cited by 11
Shukla, K. K., Badgujar, S. B., Bhanushali, P. B., & Sabharwal, S. G. (2017) · Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · doi:10.1016/j.jchromb.2017.03.010 · Cited by 7
Miklaszewska, M., Korohoda, P., Drożdż, D., Zachwieja, K., Tomasik, T., Moczulska, A., Korzeniecka‐Kozerska, A., & Kwinta, P. (2019) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/110317 · Cited by 9
Lipocalin 13 enhances insulin secretion but is dispensable for systemic metabolic control
Bühler, L., Maida, A., Vogl, E. S., Georgiadi, A., Takacs, A., Kluth, O., Schürmann, A., Feuchtinger, A., von Toerne, C., Tsokanos, F., et al. (2021) · Life Science Alliance · doi:10.26508/lsa.202000898 · Cited by 9
“…members have been discussed as therapeutic agents, for example, in immunomodulation, protection against oxidative stress, and amelioration of acute ischemic renal injury (Libert et al, 1994; Muchitsch et al, 1998; Lechner et al, 2001; Allhorn et al, 2002; Mishra et al, 2004; Mori et al, 2005).”
Is the iron donor lipocalin 2 implicated in the pathophysiology of hereditary hemochromatosis?†
Huang, H., Akira, S., & Santos, M. M. (2009) · Hepatology · doi:10.1002/hep.22699 · Cited by 9
Jobs, K., Straż-Żebrowska, E., Placzyńska, M., Zdanowski, R., Kalicki, B., Lewicki, S., & Jung, A. (2014) · Central European Journal of Immunology · doi:10.5114/ceji.2014.45952 · Cited by 9
Cellular Mechanisms of Drug Nephrotoxicity
Walker, R. J., & Endre, Z. H. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00085-9 · Cited by 10
Małyszko, J., Bachórzewska-Gajewska, H., Małyszko, J. S., Koc‐Żórawska, E., Matuszkiewicz‐Rowińska, J., & Dobrzycki, S. (2019) · Advances in Medical Sciences · doi:10.1016/j.advms.2018.12.008 · Cited by 9
Dyga, K., Machura, E., Świętochowska, E., & Szczepańska, M. (2020) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13904 · Cited by 9
Novel approaches to assessing renal function in cirrhotic liver disease
Portal, A. J., Austin, M. J., & Heneghan, M. A. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00086.x · Cited by 9
Goh, C. Y., & Ronco, C. (2010) · Journal of Renal Care · doi:10.1111/j.1755-6686.2010.00174.x · Cited by 9
Renal Biopsy: Use of Biomarkers as a Tool for the Diagnosis of Focal Segmental Glomerulosclerosis
da Silva, C. A., Cintra, M. M. M., Côbo, E. D. C., da Silva, M. V., Custódio, F. B., Corrêa, R. R. M., Castellano, L. R. C., dos Reis, M. A., & Machado, J. R. (2014) · Disease Markers · doi:10.1155/2014/192836 · Cited by 10
“Also referred to as Lipocalin-2, Siderocalin, Uterocalin, and 24p3 [124], neutrophil gelatinase-associated lipocalin is highly accumulated in human kidney cortical tubules and in the blood and urine after nephrotoxic and ischemic injuries [49, 50].”
BackgroundBiomarkers in Oncology and Nephrology
Cen, P., Walther, C. P., Finkel, K. W., & Amato, R. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415948-8.00003-9 · Cited by 8
Comparative Evaluation of Two NGAL Automated Immunoassays in Urine and Plasma
Whitehead, S. J., Chadwick, K., Ford, C., Giri, R., Luckraz, H., & Gama, R. M. (2022) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfab167 · Cited by 9
Lipocalin 2 inhibits actin glutathionylation to promote invasion and migration
Choudhary, B. S., Chaudhary, N., Shah, M., Dwivedi, N., Smitha, P. K., Das, M., & Dalal, S. N. (2023) · FEBS Letters · doi:10.1002/1873-3468.14572 · Cited by 8
Stypmann, J., Fobker, M., Rosing, K., Engelen, M. A., Gunia, S., Dell’Aquila, A. M., & Nofer, J. (2015) · Journal of Cardiology · doi:10.1016/j.jjcc.2014.12.010 · Cited by 8
“Consequently, NGAL has been suggested as a sensitive biomarker of acute kidney injury [5,6,8].”
BackgroundMorsy, S. M., Elsharawy, S., Rasslan, L., Hassan, B. A., & Khalifa, N. (2016) · Saudi Journal of Kidney Diseases and Transplantation · doi:10.4103/1319-2442.174071 · Cited by 8
Navarrete, M., Ho, J., Dwivedi, R. C., Choi, N., Ezzati, P., Spicer, V., Arora, R. C., Rigatto, C., & Wilkins, J. A. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00500 · Cited by 8
Gibbs, K. M., Izer, J. M., Reeves, W. B., Wilson, R. P., & Cooper, T. K. (2018) · Journal of the American Association for Laboratory Animal Science · doi:10.30802/aalas-jaalas-18-000062 · Cited by 8
Toxicological effects of thimerosal on rat kidney: a histological and biochemical study
Ijaz, M. U., Majeed, S. A., asharaf, A. M., Ali, T., Al‐Ghanim, K. A., Asad, F., Zafar, S., Ismail, M. V., Samad, A. R., Ahmed, Z., et al. (2023) · Brazilian Journal of Biology · doi:10.1590/1519-6984.242942 · Cited by 8
Nevo, A., Armaly, Z., Elkadir, A. A., Douvdevani, A., & Tovbin, D. (2018) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3360w · Cited by 8
“In a mouse model, direct infusion of NGAL induced tubular regeneration after ischemia and reperfusion [25]; in another study, NGAL knockout mice showed far less tubular proliferation after nephron reduction [21].”
BackgroundHemojuvelin Predicts Acute Kidney Injury and Poor Outcomes Following Cardiac Surgery
Ko, S.-W., Chi, N., Wu, C., Huang, T., Chueh, S., Wang, C., Lin, J., Wang, W., Ting, J.-T., Chang, H.-M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-20212-8 · Cited by 9
Long‐term verification of functional and structural renal damage after renal sympathetic denervation
Dörr, O., Liebetrau, C., Möllmann, H., Gaede, L., Troidl, C., Wiebe, J., Renker, M., Bauer, T., Hamm, C. W., & NEF, H. M. (2015) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.26355 · Cited by 7
Mitaka, C., Ishibashi, C., Kawagoe, I., Hashimoto, T., Takahashi, M., Satoh, D., & Inada, E. (2020) · Journal of Intensive Care · doi:10.1186/s40560-020-0428-7 · Cited by 7
“NGAL expression is highly induced not only in kidney injury [4, 5] but also bacterial infection, inflammation, and cancer [6–9].”
BackgroundShigefuku, R., Iwasa, M., Eguchi, A., Tempaku, M., Tamai, Y., Suzuki, T., & Takei, Y. (2021) · Internal Medicine · doi:10.2169/internalmedicine.7291-21 · Cited by 7
“6976 Furosemide (mg) 20 (5-35) 20 (20-40) 0.”
BackgroundUrinary Biomarkers to Predict Severe Fluid Overload After Cardiac Surgery: A Pilot Study
Elitok, S., Isermann, B., Westphal, S., Devarajan, P., Albert, C., Kuppe, H., Ernst, M., Bellomo, R., Haase, M., & Haase‐Fielitz, A. (2021) · Biomarkers in Medicine · doi:10.2217/bmm-2021-0283 · Cited by 9
Self-citationIbrahim, W., Sabry, A. A.-A., Abdelmoneim, A. R., Marzouk, H. F. A., & Abdelfattah, R. (2023) · Clinical Rheumatology · doi:10.1007/s10067-023-06698-2 · Cited by 7
“High levels of NGAL were reported after ischemic or toxic kidney injury in animal models [9], cardiovascular surgery [10], intensive care units [11], post renal transplantation graft dysfunction [12], contrast-induced nephropathy [13], cisplatin-induced nephrotoxicity [5], and Chronic Kidney…”
Park, G.-Y., Yu, C.-H., Kim, J.-S., Kang, Y.-J., Kwon, O., Choi, J., Cho, J., Kim, C., Kim, Y.-L., & Park, S.-H. (2015) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2015.30.3.345 · Cited by 7
“After renal injury, NGAL is increased significantly in human kidney cortical tubules, blood, and urine [8].”
BackgroundUrine Levels of Defensin α1 Reflect Kidney Injury in Leptospirosis Patients
Yasutan, H. C., Chen, Y., Lacuesta, T. L., Leaño, P. S. A., Iwasaki, H., Hanan, F., Taurustiati, D., Ohmoto, Y., Ashino, Y., Saitoh, H., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101637 · Cited by 7
“It was already known that /Cr and uNAG/Cr levels are sign ficantly co related with serum Cr [16,17].”
BackgroundKim, H. S., Kim, J., Lee, S. M., Park, H. J., Lee, S., Jang, J. S., & Lee, M. H. (2019) · Microbiology and Biotechnology Letters · doi:10.4014/mbl.1904.04001 · Cited by 7
“위의 Fe을 식물 및 유용 미생물이 흡수할 수 있도록 하여 결 과적으로, 식물 병원성 곰팡이의 Fe 흡수를 방해하여 생육 하는 것을 억제할 수 있을 것으로 기대된다[27, 28].”
Passov, A., Ilmakunnas, M., Pihlajoki, M., Hermunen, K. M., Lempinen, M., Helanterä, I., Kailari, V., Heikinheimo, M., ANDERSSON, S. M., & Pesonen, E. (2021) · Intensive Care Medicine Experimental · doi:10.1186/s40635-021-00422-7 · Cited by 7
“In experimental studies, proximal tubular cells rapidly take up intravenously administered NGAL and degrade it in lysosomes, and do not release NGAL back into the circulation [7].”
BackgroundFauzi, A. S., Salasia, S. I. O., & Titisari, N. (2015) · Comparative Clinical Pathology · doi:10.1007/s00580-015-2195-8 · Cited by 7
“NGAL protein accumulates in the blood, urine, proximal and distal renal tubules following damage (Mori et al. 2005).”
Anticalins in Drug Development
Schlehuber, S., & Skerra, A. (2005) · BioDrugs · doi:10.2165/00063030-200519050-00001 · Cited by 9
Polat, M., Fidan, K., Derinöz, O., Gönen, S., & Söylemezoğlu, O. (2013) · Renal Failure · doi:10.3109/0886022x.2013.764273 · Cited by 7
“Mori et al.(6) reported that NGAL is highly accumulated in the human kidney cortical tubules, blood, and urine, after nephrotoxic and ischemic injuries.”
BackgroundPrognostic Value of NGAL Staining in Patients with IgA Nephropathy
Yavas, H., Sahin, O. Z., Ersoy, R., Taşlı, F., Genek, D. G., Üzüm, A., & Cirit, M. (2013) · Renal Failure · doi:10.3109/0886022x.2013.767114 · Cited by 7
“The investigators showed that serum and urine levels of NGAL increases in renal injuries such as renal ischemia, kidney parenchymal disease (glomerulonephritis, minimal change disease, focal segmental glomerulosclerosis, and diabetic nephropathy), hemolytic uremic syndrome, and post-transplantation rejection.(8) NGAL…”
BackgroundParravicini, E., Locatelli, C., Lorenz, J. M., Nemerofsky, S. L., & Bateman, D. (2016) · Pediatric Research · doi:10.1038/pr.2016.138 · Cited by 7
Oxymatrine on Hsp90a expression and apoptosis in a model of lung ischemia-reperfusion injury
Zhu, B., Yang, J., Chen, S., Zhang, P., Shen, L., Li, X., & Li, J. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4098 · Cited by 7
“Ischemia-reperfusion injury (IRI) is a disease caused by ischemia, reperfusion or revascularization to dredge by vascular tissues and organs regain blood, in certain circumstances, the reperfusion will result in more serious damage to tissues and cells (1-3).”
BackgroundSelf-citationForster, C. S., Goldstein, S. L., Pohl, H. G., & Jackson, E. (2019) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2018.12.008 · Cited by 7
Aslanhan, E., Ojalvo, D., Özşenel, E. B., Basat, S., & Borlu, F. (2019) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000180 · Cited by 7
Amin, R., He, R., Gupta, D., Zheng, W., Burmakin, M., Mohammad, D. K., DePierre, J. W., Sadeghi, B., Olauson, H., Wernerson, A. M., et al. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.106042 · Cited by 7
Neutrophil Gelatinase-Associated Lipocalin as a Promising Biomarker in Acute Kidney Injury
Lima, C., Vattimo, M. D. F. F., & Macedo, E. M. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.93650 · Cited by 7
Metadata
- Authors
- Mori, K., Lee, H. T., Rapoport, D., Drexler, I. R., Foster, K., Yang, J., Schmidt-Ott, K. M., Chen, X., Li, J. Y., Weiss, S., Mishra, J., Cheema, F. H., Markowitz, G., Suganami, T., Sawai, K., Mukoyama, M., Kunis, C., D’Agati, V., Devarajan, P., & Barasch, J.
- Affiliations
- Columbia University (US)
- Nebraska Medical Center (US)
- Cincinnati Children's Hospital Medical Center (US)
- Kyoto University (JP)
- Corresponding author
- Barasch, Jonathan
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2005-03-01
- Volume
- 115
- Issue
- 3
- Pages
- 610-621
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC548316
- OpenAlex
- W2122934045
- Cited by
- 954
- References
- 101
- Citations by year
- 2026: 13 · 2025: 21 · 2024: 26 · 2023: 25 · 2022: 25 · 2021: 43 · 2020: 37 · 2019: 53 · 2018: 41 · 2017: 47 · 2016: 64 · 2015: 55 · 2014: 57 · 2013: 69 · 2012: 88
- FWCI
- 22.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- Funders
- March of Dimes Foundation
- Strong
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (P01DK055388, DK58872, R01DK058872, DK55388)
- Topics
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- neutrophil gelatinase-associated lipocalin, siderocalin, siderophores, iron delivery, renal ischemia-reperfusion injury, renal protection, proximal tubule, heme oxygenase-1, N-cadherin, gallium, azotemia, iron trafficking, renal failure
- MeSH terms
- Lipocalin-2, Acute-Phase Proteins, Animals, Creatinine, Endocytosis, Epithelial Cells, Heme Oxygenase (Decyclizing), Humans, Iron, Kidney, Kidney Cortex Necrosis, Kidney Tubules, Male, Membrane Proteins, Mice, Inbred C57BL, Proto-Oncogene Proteins, Reperfusion Injury, Oncogene Proteins, Siderophores, Macromolecular Substances, Mice, Heme Oxygenase-1, Lipocalins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.